Limoneira, Calavo both report earnings growth as produce industry continues recovery
Santa Paula-based agribusinesses Limoneira and Calavo Growers both reported positive earnings in their second quarter financial results released June 8, with both saying their earnings mark a return back to pre-pandemic form. Limoneira reported earnings of $1.5 million for the quarter, or 10 cents per share, up from a loss of $5.3 million in the Read More →
Read More →
Amgen’s new drug could be a blockbuster
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Semtech shares up after company reports income and revenue growth
Semtech Corp., a Camarillo semiconductor company specializing in Internet of Things applications, saw its income and revenue rise in the first quarter of fiscal year 2021-22, thanks in large part to growth in its wireless and sensing products market. Semtech saw revenue rise 28% year-over-year to $170.4 million, the company said when it released its Read More →
Read More →Amgen reaches billion-dollar licensing deal with Japanese firm
Amgen announced an agreement June 1 with Kyowa Kirin, a Japanese pharmaceutical company, to jointly develop and commercialize a human monoclonal antibody that Kyowa Kirin is developing to treat atopic dermatitis and other autoimmune diseases. The deal could be worth $1.25 billion or more. Amgen will led the development, manufacturing and commercialization for the treatment, Read More →
Read More →Opinion: Remembering David Swensen, a giant in the investment world
By David Kreinces In early May, David Swensen, Yale’s legendary endowment chief, died of cancer at age 67. Swensen was famous on Wall Street for successfully diversifying Yale’s portfolio in a wide range of alternative investments, and he was also loved for his 2005 book on exchange-traded funds (ETFs). The book, “Unconventional Success,” showed Swensen’s Read More →
Read More →Amgen gets FDA approval for potential billion-dollar drug
Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 28 for its latest oral drug treatment, Lumakras, potentially adding another huge market for one of the largest biotech firms in the world. According to the Wall Street Journal, Amgen will charge $17,900 a month for the drug and analyst think Read More →
Read More →QAD stock rises after earnings beat
QAD, a Santa Barbara-based cloud software company for the manufacturing industry, beat analysts’ expectations with its earning for the first quarter of its 2021-22 fiscal year on May 26. QAD’s net income for the quarter was $1.8 million, or 7 cents per share, compared to a loss of $410,000 in the same quarter a year Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
